Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Cognitive Neuroscience Market

ID: MRFR/HC/30491-HCR
100 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Cognitive Neuroscience Market Research Report By Research Application (Neuroimaging, Behavioral Analysis, Cognitive Assessment, Electrophysiological Studies), By End User (Academic Institutions, Research Organizations, Healthcare Providers, Pharmaceutical Companies), By Product Type (Hardware, Software, Services), By Methodology (Functional Magnetic Resonance Imaging (fMRI), Electroencephalography (EEG), Transcranial Magnetic Stimulation (TMS)), By Funding Source (Government Grants, Private Investments, Industry Sponsorship) and  By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)  - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Cognitive Neuroscience Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Research Application (USD Billion)
  49.     4.1.1 Neuroimaging
  50.     4.1.2 Behavioral Analysis
  51.     4.1.3 Cognitive Assessment
  52.     4.1.4 Electrophysiological Studies
  53.   4.2 Healthcare, BY End User (USD Billion)
  54.     4.2.1 Academic Institutions
  55.     4.2.2 Research Organizations
  56.     4.2.3 Healthcare Providers
  57.     4.2.4 Pharmaceutical Companies
  58.   4.3 Healthcare, BY Product Type (USD Billion)
  59.     4.3.1 Hardware
  60.     4.3.2 Software
  61.     4.3.3 Services
  62.   4.4 Healthcare, BY Methodology (USD Billion)
  63.     4.4.1 Functional Magnetic Resonance Imaging (fMRI)
  64.     4.4.2 Electroencephalography (EEG)
  65.     4.4.3 Transcranial Magnetic Stimulation (TMS)
  66.   4.5 Healthcare, BY Funding Source (USD Billion)
  67.     4.5.1 Government Grants
  68.     4.5.2 Private Investments
  69.     4.5.3 Industry Sponsorship
  70.   4.6 Healthcare, BY Region (USD Billion)
  71.     4.6.1 North America
  72.       4.6.1.1 US
  73.       4.6.1.2 Canada
  74.     4.6.2 Europe
  75.       4.6.2.1 Germany
  76.       4.6.2.2 UK
  77.       4.6.2.3 France
  78.       4.6.2.4 Russia
  79.       4.6.2.5 Italy
  80.       4.6.2.6 Spain
  81.       4.6.2.7 Rest of Europe
  82.     4.6.3 APAC
  83.       4.6.3.1 China
  84.       4.6.3.2 India
  85.       4.6.3.3 Japan
  86.       4.6.3.4 South Korea
  87.       4.6.3.5 Malaysia
  88.       4.6.3.6 Thailand
  89.       4.6.3.7 Indonesia
  90.       4.6.3.8 Rest of APAC
  91.     4.6.4 South America
  92.       4.6.4.1 Brazil
  93.       4.6.4.2 Mexico
  94.       4.6.4.3 Argentina
  95.       4.6.4.4 Rest of South America
  96.     4.6.5 MEA
  97.       4.6.5.1 GCC Countries
  98.       4.6.5.2 South Africa
  99.       4.6.5.3 Rest of MEA
  100. 5 SECTION V: COMPETITIVE ANALYSIS
  101.   5.1 Competitive Landscape
  102.     5.1.1 Overview
  103.     5.1.2 Competitive Analysis
  104.     5.1.3 Market share Analysis
  105.     5.1.4 Major Growth Strategy in the Healthcare
  106.     5.1.5 Competitive Benchmarking
  107.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  108.     5.1.7 Key developments and growth strategies
  109.       5.1.7.1 New Product Launch/Service Deployment
  110.       5.1.7.2 Merger & Acquisitions
  111.       5.1.7.3 Joint Ventures
  112.     5.1.8 Major Players Financial Matrix
  113.       5.1.8.1 Sales and Operating Income
  114.       5.1.8.2 Major Players R&D Expenditure. 2023
  115.   5.2 Company Profiles
  116.     5.2.1 Neuroscience Technologies (US)
  117.       5.2.1.1 Financial Overview
  118.       5.2.1.2 Products Offered
  119.       5.2.1.3 Key Developments
  120.       5.2.1.4 SWOT Analysis
  121.       5.2.1.5 Key Strategies
  122.     5.2.2 Cerebrum Inc (US)
  123.       5.2.2.1 Financial Overview
  124.       5.2.2.2 Products Offered
  125.       5.2.2.3 Key Developments
  126.       5.2.2.4 SWOT Analysis
  127.       5.2.2.5 Key Strategies
  128.     5.2.3 NeuroScience Solutions (US)
  129.       5.2.3.1 Financial Overview
  130.       5.2.3.2 Products Offered
  131.       5.2.3.3 Key Developments
  132.       5.2.3.4 SWOT Analysis
  133.       5.2.3.5 Key Strategies
  134.     5.2.4 Cognitive Dynamics (US)
  135.       5.2.4.1 Financial Overview
  136.       5.2.4.2 Products Offered
  137.       5.2.4.3 Key Developments
  138.       5.2.4.4 SWOT Analysis
  139.       5.2.4.5 Key Strategies
  140.     5.2.5 Brain Health Innovations (US)
  141.       5.2.5.1 Financial Overview
  142.       5.2.5.2 Products Offered
  143.       5.2.5.3 Key Developments
  144.       5.2.5.4 SWOT Analysis
  145.       5.2.5.5 Key Strategies
  146.     5.2.6 NeuroTech Labs (US)
  147.       5.2.6.1 Financial Overview
  148.       5.2.6.2 Products Offered
  149.       5.2.6.3 Key Developments
  150.       5.2.6.4 SWOT Analysis
  151.       5.2.6.5 Key Strategies
  152.     5.2.7 Mind Research Institute (US)
  153.       5.2.7.1 Financial Overview
  154.       5.2.7.2 Products Offered
  155.       5.2.7.3 Key Developments
  156.       5.2.7.4 SWOT Analysis
  157.       5.2.7.5 Key Strategies
  158.     5.2.8 Cognitive Neuroscience Group (GB)
  159.       5.2.8.1 Financial Overview
  160.       5.2.8.2 Products Offered
  161.       5.2.8.3 Key Developments
  162.       5.2.8.4 SWOT Analysis
  163.       5.2.8.5 Key Strategies
  164.   5.3 Appendix
  165.     5.3.1 References
  166.     5.3.2 Related Reports
  167. 6 LIST OF FIGURES
  168.   6.1 MARKET SYNOPSIS
  169.   6.2 NORTH AMERICA MARKET ANALYSIS
  170.   6.3 US MARKET ANALYSIS BY RESEARCH APPLICATION
  171.   6.4 US MARKET ANALYSIS BY END USER
  172.   6.5 US MARKET ANALYSIS BY PRODUCT TYPE
  173.   6.6 US MARKET ANALYSIS BY METHODOLOGY
  174.   6.7 US MARKET ANALYSIS BY FUNDING SOURCE
  175.   6.8 CANADA MARKET ANALYSIS BY RESEARCH APPLICATION
  176.   6.9 CANADA MARKET ANALYSIS BY END USER
  177.   6.10 CANADA MARKET ANALYSIS BY PRODUCT TYPE
  178.   6.11 CANADA MARKET ANALYSIS BY METHODOLOGY
  179.   6.12 CANADA MARKET ANALYSIS BY FUNDING SOURCE
  180.   6.13 EUROPE MARKET ANALYSIS
  181.   6.14 GERMANY MARKET ANALYSIS BY RESEARCH APPLICATION
  182.   6.15 GERMANY MARKET ANALYSIS BY END USER
  183.   6.16 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
  184.   6.17 GERMANY MARKET ANALYSIS BY METHODOLOGY
  185.   6.18 GERMANY MARKET ANALYSIS BY FUNDING SOURCE
  186.   6.19 UK MARKET ANALYSIS BY RESEARCH APPLICATION
  187.   6.20 UK MARKET ANALYSIS BY END USER
  188.   6.21 UK MARKET ANALYSIS BY PRODUCT TYPE
  189.   6.22 UK MARKET ANALYSIS BY METHODOLOGY
  190.   6.23 UK MARKET ANALYSIS BY FUNDING SOURCE
  191.   6.24 FRANCE MARKET ANALYSIS BY RESEARCH APPLICATION
  192.   6.25 FRANCE MARKET ANALYSIS BY END USER
  193.   6.26 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
  194.   6.27 FRANCE MARKET ANALYSIS BY METHODOLOGY
  195.   6.28 FRANCE MARKET ANALYSIS BY FUNDING SOURCE
  196.   6.29 RUSSIA MARKET ANALYSIS BY RESEARCH APPLICATION
  197.   6.30 RUSSIA MARKET ANALYSIS BY END USER
  198.   6.31 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
  199.   6.32 RUSSIA MARKET ANALYSIS BY METHODOLOGY
  200.   6.33 RUSSIA MARKET ANALYSIS BY FUNDING SOURCE
  201.   6.34 ITALY MARKET ANALYSIS BY RESEARCH APPLICATION
  202.   6.35 ITALY MARKET ANALYSIS BY END USER
  203.   6.36 ITALY MARKET ANALYSIS BY PRODUCT TYPE
  204.   6.37 ITALY MARKET ANALYSIS BY METHODOLOGY
  205.   6.38 ITALY MARKET ANALYSIS BY FUNDING SOURCE
  206.   6.39 SPAIN MARKET ANALYSIS BY RESEARCH APPLICATION
  207.   6.40 SPAIN MARKET ANALYSIS BY END USER
  208.   6.41 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
  209.   6.42 SPAIN MARKET ANALYSIS BY METHODOLOGY
  210.   6.43 SPAIN MARKET ANALYSIS BY FUNDING SOURCE
  211.   6.44 REST OF EUROPE MARKET ANALYSIS BY RESEARCH APPLICATION
  212.   6.45 REST OF EUROPE MARKET ANALYSIS BY END USER
  213.   6.46 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
  214.   6.47 REST OF EUROPE MARKET ANALYSIS BY METHODOLOGY
  215.   6.48 REST OF EUROPE MARKET ANALYSIS BY FUNDING SOURCE
  216.   6.49 APAC MARKET ANALYSIS
  217.   6.50 CHINA MARKET ANALYSIS BY RESEARCH APPLICATION
  218.   6.51 CHINA MARKET ANALYSIS BY END USER
  219.   6.52 CHINA MARKET ANALYSIS BY PRODUCT TYPE
  220.   6.53 CHINA MARKET ANALYSIS BY METHODOLOGY
  221.   6.54 CHINA MARKET ANALYSIS BY FUNDING SOURCE
  222.   6.55 INDIA MARKET ANALYSIS BY RESEARCH APPLICATION
  223.   6.56 INDIA MARKET ANALYSIS BY END USER
  224.   6.57 INDIA MARKET ANALYSIS BY PRODUCT TYPE
  225.   6.58 INDIA MARKET ANALYSIS BY METHODOLOGY
  226.   6.59 INDIA MARKET ANALYSIS BY FUNDING SOURCE
  227.   6.60 JAPAN MARKET ANALYSIS BY RESEARCH APPLICATION
  228.   6.61 JAPAN MARKET ANALYSIS BY END USER
  229.   6.62 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
  230.   6.63 JAPAN MARKET ANALYSIS BY METHODOLOGY
  231.   6.64 JAPAN MARKET ANALYSIS BY FUNDING SOURCE
  232.   6.65 SOUTH KOREA MARKET ANALYSIS BY RESEARCH APPLICATION
  233.   6.66 SOUTH KOREA MARKET ANALYSIS BY END USER
  234.   6.67 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
  235.   6.68 SOUTH KOREA MARKET ANALYSIS BY METHODOLOGY
  236.   6.69 SOUTH KOREA MARKET ANALYSIS BY FUNDING SOURCE
  237.   6.70 MALAYSIA MARKET ANALYSIS BY RESEARCH APPLICATION
  238.   6.71 MALAYSIA MARKET ANALYSIS BY END USER
  239.   6.72 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
  240.   6.73 MALAYSIA MARKET ANALYSIS BY METHODOLOGY
  241.   6.74 MALAYSIA MARKET ANALYSIS BY FUNDING SOURCE
  242.   6.75 THAILAND MARKET ANALYSIS BY RESEARCH APPLICATION
  243.   6.76 THAILAND MARKET ANALYSIS BY END USER
  244.   6.77 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
  245.   6.78 THAILAND MARKET ANALYSIS BY METHODOLOGY
  246.   6.79 THAILAND MARKET ANALYSIS BY FUNDING SOURCE
  247.   6.80 INDONESIA MARKET ANALYSIS BY RESEARCH APPLICATION
  248.   6.81 INDONESIA MARKET ANALYSIS BY END USER
  249.   6.82 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
  250.   6.83 INDONESIA MARKET ANALYSIS BY METHODOLOGY
  251.   6.84 INDONESIA MARKET ANALYSIS BY FUNDING SOURCE
  252.   6.85 REST OF APAC MARKET ANALYSIS BY RESEARCH APPLICATION
  253.   6.86 REST OF APAC MARKET ANALYSIS BY END USER
  254.   6.87 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
  255.   6.88 REST OF APAC MARKET ANALYSIS BY METHODOLOGY
  256.   6.89 REST OF APAC MARKET ANALYSIS BY FUNDING SOURCE
  257.   6.90 SOUTH AMERICA MARKET ANALYSIS
  258.   6.91 BRAZIL MARKET ANALYSIS BY RESEARCH APPLICATION
  259.   6.92 BRAZIL MARKET ANALYSIS BY END USER
  260.   6.93 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
  261.   6.94 BRAZIL MARKET ANALYSIS BY METHODOLOGY
  262.   6.95 BRAZIL MARKET ANALYSIS BY FUNDING SOURCE
  263.   6.96 MEXICO MARKET ANALYSIS BY RESEARCH APPLICATION
  264.   6.97 MEXICO MARKET ANALYSIS BY END USER
  265.   6.98 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
  266.   6.99 MEXICO MARKET ANALYSIS BY METHODOLOGY
  267.   6.100 MEXICO MARKET ANALYSIS BY FUNDING SOURCE
  268.   6.101 ARGENTINA MARKET ANALYSIS BY RESEARCH APPLICATION
  269.   6.102 ARGENTINA MARKET ANALYSIS BY END USER
  270.   6.103 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
  271.   6.104 ARGENTINA MARKET ANALYSIS BY METHODOLOGY
  272.   6.105 ARGENTINA MARKET ANALYSIS BY FUNDING SOURCE
  273.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY RESEARCH APPLICATION
  274.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  275.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
  276.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY METHODOLOGY
  277.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNDING SOURCE
  278.   6.111 MEA MARKET ANALYSIS
  279.   6.112 GCC COUNTRIES MARKET ANALYSIS BY RESEARCH APPLICATION
  280.   6.113 GCC COUNTRIES MARKET ANALYSIS BY END USER
  281.   6.114 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
  282.   6.115 GCC COUNTRIES MARKET ANALYSIS BY METHODOLOGY
  283.   6.116 GCC COUNTRIES MARKET ANALYSIS BY FUNDING SOURCE
  284.   6.117 SOUTH AFRICA MARKET ANALYSIS BY RESEARCH APPLICATION
  285.   6.118 SOUTH AFRICA MARKET ANALYSIS BY END USER
  286.   6.119 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
  287.   6.120 SOUTH AFRICA MARKET ANALYSIS BY METHODOLOGY
  288.   6.121 SOUTH AFRICA MARKET ANALYSIS BY FUNDING SOURCE
  289.   6.122 REST OF MEA MARKET ANALYSIS BY RESEARCH APPLICATION
  290.   6.123 REST OF MEA MARKET ANALYSIS BY END USER
  291.   6.124 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
  292.   6.125 REST OF MEA MARKET ANALYSIS BY METHODOLOGY
  293.   6.126 REST OF MEA MARKET ANALYSIS BY FUNDING SOURCE
  294.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  295.   6.128 RESEARCH PROCESS OF MRFR
  296.   6.129 DRO ANALYSIS OF HEALTHCARE
  297.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  298.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  299.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  300.   6.133 HEALTHCARE, BY RESEARCH APPLICATION, 2024 (% SHARE)
  301.   6.134 HEALTHCARE, BY RESEARCH APPLICATION, 2024 TO 2035 (USD Billion)
  302.   6.135 HEALTHCARE, BY END USER, 2024 (% SHARE)
  303.   6.136 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  304.   6.137 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  305.   6.138 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  306.   6.139 HEALTHCARE, BY METHODOLOGY, 2024 (% SHARE)
  307.   6.140 HEALTHCARE, BY METHODOLOGY, 2024 TO 2035 (USD Billion)
  308.   6.141 HEALTHCARE, BY FUNDING SOURCE, 2024 (% SHARE)
  309.   6.142 HEALTHCARE, BY FUNDING SOURCE, 2024 TO 2035 (USD Billion)
  310.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  311. 7 LIST OF TABLES
  312.   7.1 LIST OF ASSUMPTIONS
  313.     7.1.1
  314.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  315.     7.2.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  316.     7.2.2 BY END USER, 2025-2035 (USD Billion)
  317.     7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  318.     7.2.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  319.     7.2.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  320.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  321.     7.3.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  322.     7.3.2 BY END USER, 2025-2035 (USD Billion)
  323.     7.3.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  324.     7.3.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  325.     7.3.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  326.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  327.     7.4.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  328.     7.4.2 BY END USER, 2025-2035 (USD Billion)
  329.     7.4.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  330.     7.4.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  331.     7.4.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  332.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  333.     7.5.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  334.     7.5.2 BY END USER, 2025-2035 (USD Billion)
  335.     7.5.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  336.     7.5.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  337.     7.5.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  338.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  339.     7.6.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  340.     7.6.2 BY END USER, 2025-2035 (USD Billion)
  341.     7.6.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  342.     7.6.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  343.     7.6.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  344.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  345.     7.7.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  346.     7.7.2 BY END USER, 2025-2035 (USD Billion)
  347.     7.7.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  348.     7.7.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  349.     7.7.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  350.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  351.     7.8.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  352.     7.8.2 BY END USER, 2025-2035 (USD Billion)
  353.     7.8.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  354.     7.8.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  355.     7.8.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  356.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  357.     7.9.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  358.     7.9.2 BY END USER, 2025-2035 (USD Billion)
  359.     7.9.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  360.     7.9.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  361.     7.9.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  362.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  363.     7.10.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  364.     7.10.2 BY END USER, 2025-2035 (USD Billion)
  365.     7.10.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  366.     7.10.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  367.     7.10.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  368.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  369.     7.11.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  370.     7.11.2 BY END USER, 2025-2035 (USD Billion)
  371.     7.11.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  372.     7.11.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  373.     7.11.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  374.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  375.     7.12.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  376.     7.12.2 BY END USER, 2025-2035 (USD Billion)
  377.     7.12.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  378.     7.12.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  379.     7.12.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  380.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  381.     7.13.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  382.     7.13.2 BY END USER, 2025-2035 (USD Billion)
  383.     7.13.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  384.     7.13.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  385.     7.13.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  386.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  387.     7.14.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  388.     7.14.2 BY END USER, 2025-2035 (USD Billion)
  389.     7.14.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  390.     7.14.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  391.     7.14.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  392.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  393.     7.15.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  394.     7.15.2 BY END USER, 2025-2035 (USD Billion)
  395.     7.15.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  396.     7.15.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  397.     7.15.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  398.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  399.     7.16.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  400.     7.16.2 BY END USER, 2025-2035 (USD Billion)
  401.     7.16.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  402.     7.16.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  403.     7.16.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  404.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  405.     7.17.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  406.     7.17.2 BY END USER, 2025-2035 (USD Billion)
  407.     7.17.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  408.     7.17.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  409.     7.17.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  410.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  411.     7.18.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  412.     7.18.2 BY END USER, 2025-2035 (USD Billion)
  413.     7.18.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  414.     7.18.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  415.     7.18.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  416.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  417.     7.19.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  418.     7.19.2 BY END USER, 2025-2035 (USD Billion)
  419.     7.19.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  420.     7.19.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  421.     7.19.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  422.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  423.     7.20.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  424.     7.20.2 BY END USER, 2025-2035 (USD Billion)
  425.     7.20.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  426.     7.20.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  427.     7.20.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  428.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  429.     7.21.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  430.     7.21.2 BY END USER, 2025-2035 (USD Billion)
  431.     7.21.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  432.     7.21.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  433.     7.21.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  434.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  435.     7.22.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  436.     7.22.2 BY END USER, 2025-2035 (USD Billion)
  437.     7.22.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  438.     7.22.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  439.     7.22.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  440.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  441.     7.23.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  442.     7.23.2 BY END USER, 2025-2035 (USD Billion)
  443.     7.23.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  444.     7.23.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  445.     7.23.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  446.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  447.     7.24.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  448.     7.24.2 BY END USER, 2025-2035 (USD Billion)
  449.     7.24.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  450.     7.24.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  451.     7.24.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  452.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  453.     7.25.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  454.     7.25.2 BY END USER, 2025-2035 (USD Billion)
  455.     7.25.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  456.     7.25.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  457.     7.25.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  458.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  459.     7.26.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  460.     7.26.2 BY END USER, 2025-2035 (USD Billion)
  461.     7.26.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  462.     7.26.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  463.     7.26.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  464.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  465.     7.27.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  466.     7.27.2 BY END USER, 2025-2035 (USD Billion)
  467.     7.27.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  468.     7.27.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  469.     7.27.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  470.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  471.     7.28.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  472.     7.28.2 BY END USER, 2025-2035 (USD Billion)
  473.     7.28.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  474.     7.28.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  475.     7.28.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  476.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  477.     7.29.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  478.     7.29.2 BY END USER, 2025-2035 (USD Billion)
  479.     7.29.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  480.     7.29.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  481.     7.29.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  482.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  483.     7.30.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
  484.     7.30.2 BY END USER, 2025-2035 (USD Billion)
  485.     7.30.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  486.     7.30.4 BY METHODOLOGY, 2025-2035 (USD Billion)
  487.     7.30.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
  488.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  489.     7.31.1
  490.   7.32 ACQUISITION/PARTNERSHIP
  491.     7.32.1

Healthcare Market Segmentation

Healthcare By Research Application (USD Billion, 2025-2035)

  • Neuroimaging
  • Behavioral Analysis
  • Cognitive Assessment
  • Electrophysiological Studies

Healthcare By End User (USD Billion, 2025-2035)

  • Academic Institutions
  • Research Organizations
  • Healthcare Providers
  • Pharmaceutical Companies

Healthcare By Product Type (USD Billion, 2025-2035)

  • Hardware
  • Software
  • Services

Healthcare By Methodology (USD Billion, 2025-2035)

  • Functional Magnetic Resonance Imaging (fMRI)
  • Electroencephalography (EEG)
  • Transcranial Magnetic Stimulation (TMS)

Healthcare By Funding Source (USD Billion, 2025-2035)

  • Government Grants
  • Private Investments
  • Industry Sponsorship

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions